Dermal Substitution in Pediatric Burns
GlyPeB
Dermal Substitution in Paediatric Burns: A Prospective Case Series
1 other identifier
interventional
20
1 country
1
Brief Summary
The standard treatment of deep dermal to full thickness burns is surgical removal of the burn followed by skin transplantation. Dermal substitutes are increasingly used in the treatment of deep burns to replace lost dermis. Preservation of the collagen and elastin in the acellular human dermal substitute Glyaderm provides a more elastic scar. It is unknown what the effect of Glyaderm on scar quality is in a solely paediatric population. The objective of this case series is to investigate scar maturation and scar quality when applying Glyaderm in deep dermal to full thickness burns in a pediatric population aged ≤15 years old.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedApril 12, 2024
November 1, 2023
3.2 years
March 15, 2022
April 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Scar quality (clinician)
Scar quality measured using the Patient and Observer Scar Assessment Scale (POSAS) Observer Scale, which rates the scar from 1 (=like normal skin) to 10 (=worst scar imaginable).
12 months
Secondary Outcomes (9)
Clinical assessment of the graft take
5-7 days after STSG application
Wound epithelialization
5-7 days after STSG application
Wound healing time
determined in the first several days to weeks after STSG application
Donor site healing time
determined in the first several days to weeks after STSG application
Scar surface area
day of surgery (day 0) and 3, 6 and 12 months post-surgery
- +4 more secondary outcomes
Study Arms (1)
Glyaderm
EXPERIMENTALInterventions
All included patients will undergo full thickness removal of the burned skin or adequate debridement of all necrotic tissue. Next, the dermal substitute Glyaderm followed by a split thickness skin graft will be transplanted on the wound.
Eligibility Criteria
You may qualify if:
- Age ≤15 years old
- Burn wounds requiring skin grafting
- Written informed consent provided by
- The participant's parent(s)/guardian (\<12 years of age)
- The participant's parent(s)/guardian and the participant itself (12-15 years old)
You may not qualify if:
- Burn wound of ≤30 cm2
- Infected burn wounds: clinical symptoms in combination with positive wound swabs
- Patients/parents with insufficient knowledge of the Dutch or English language, since they would not be able to complete the POSAS questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboudumc
Nijmegen, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marielle Vehmeijer-Heeman, MD, PhD
Radboud University Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2022
First Posted
April 4, 2022
Study Start
September 1, 2022
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
April 12, 2024
Record last verified: 2023-11